Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIPAC: Simvastatin After Cardioversion of Atrial Fibrillation
2006-003119-35Phase 2Terminated
- Sponsor
- Medical University of Vienna
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of simvastatin in Atrial fibrillation (AFib), sponsored by Medical University of Vienna. Primary endpoint: High-sensitivity C-reactive protein (hs-CRP) levels. Started Oct 2006; status: terminated.
02
Drugs
simvastatin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2006-003119-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003119-35.